nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure
|
Jungbluth, Stefan |
|
|
76 |
C |
p. 15-23 |
artikel |
2 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
|
76 |
C |
p. IFC |
artikel |
3 |
Autogenous vaccines: Quality of production and movement in a common market
|
Grein, Kornelia |
|
|
76 |
C |
p. 36-41 |
artikel |
4 |
Evolution of FMT – From early clinical to standardized treatments
|
Servetas, Stephanie L. |
|
|
76 |
C |
p. 31-35 |
artikel |
5 |
Glycoconjugate content quantification to assess vaccine potency: A simplified approach
|
Rech, Francesca |
|
|
76 |
C |
p. 10-14 |
artikel |
6 |
National Control Laboratories in quality healthcare-a roadblock for substandard biopharmaceuticals
|
Shrivastava, Rashmi |
|
|
76 |
C |
p. 42-45 |
artikel |
7 |
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression
|
Alidoust Saharkhiz Lahiji, Mahsa |
|
|
76 |
C |
p. 24-30 |
artikel |
8 |
WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June – 2 July 2021
|
Wadhwa, Meenu |
|
|
76 |
C |
p. 1-9 |
artikel |